Compare VCYT & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCYT | LU |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 2013 | 2020 |
| Metric | VCYT | LU |
|---|---|---|
| Price | $32.88 | $2.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $45.13 | N/A |
| AVG Volume (30 Days) | 810.9K | ★ 1.3M |
| Earning Date | 05-06-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.52 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.33 | N/A |
| Revenue Next Year | $12.53 | $22.52 |
| P/E Ratio | $40.47 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.61 | $2.22 |
| 52 Week High | $50.71 | $4.57 |
| Indicator | VCYT | LU |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 29.96 |
| Support Level | $31.22 | N/A |
| Resistance Level | $34.89 | $2.77 |
| Average True Range (ATR) | 1.19 | 0.08 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 36.34 | 5.81 |
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.